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Abstract
The goal of the 1000 Genomes Consortium is to characterize human genome structural variation (SV), including forms of copy
number variations such as deletions, duplications, and insertions. Mobile element insertions, particularly Alu elements, are major
contributors to genomic SV among humans. During the pilot phase of the project we experimentally validated 645 (611 intergenic
and 34 exon targeted) polymorphic “young” Alu insertion events, absent from the human reference genome. Here, we report high
resolution sequencing of 343 (322 unique) recent Alu insertion events, along with their respective target site duplications, precise
genomic breakpoint coordinates, subfamily assignment, percent divergence, and estimated A-rich tail lengths. All the sequenced Alu
loci were derived from the AluY lineage with no evidence of retrotransposition activity involving older Alu families (e.g., AluJ and AluS).
AluYa5 is currently the most active Alu subfamily in the human lineage, followed by AluYb8, and many others including three newly
identified subfamilies we have termed AluYb7a3, AluYb8b1, and AluYa4a1. This report provides the structural details of 322 unique
Alu variants from individual human genomes collectively adding about 100 kb of genomic variation. Many Alu subfamilies are
currently active in human populations, including a surprising level of AluY retrotransposition. Human Alu subfamilies exhibit continuous evolution with potential drivers sprouting new Alu lineages.
Key words: retrotransposon, mobilome, structural variation.

Introduction
The 1000 Genomes Project is an ongoing series of studies
designed to comprehensively identify and characterize all
forms of human genomic variation (Abecasis et al. 2010), as
well as identify specific types of structural variation (SVs) and
their origin and impact on human populations (Mills et al.
2011; Abecasis et al. 2012). The Pilot phase of the project
was the first to employ advances in second-generation DNA
sequencing technologies to perform population scale highthroughput genome-wide sequencing on multiple human

individuals. The two primary second-generation strategies to
detect SVs involved a “read-pair” (RP) method applied to
Illumina paired-end short sequence reads and a complimentary “split-read” (SR) method applied to longer pyrosequencing reads generated by the Roche/454 platform (Stewart
et al. 2011). The Pilot phase was comprised of three strategic
approaches, low-coverage, high-coverage, and exon-targeted
sequencing (Abecasis et al. 2010). The “low-coverage project” or “P1” consisted of 179 unrelated individuals who were
sequenced with an average of 3.6 coverage, including 59
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Although recent studies have shown that secondgeneration sequencing represents a powerful tool to
identify SVs, including MEIs, with relatively low false positive detection rates, the need for detailed and widespread validations, especially in regions with high
repeat content, has become evident (Mills et al. 2011;
Stewart et al. 2011). During the Pilot phase of the 1000
Genomes Project, roughly 4,500 recent Alu insertion
events absent from the human reference genome
[hg18] were discovered (Stewart et al. 2011).
Approximately 200 elements were randomly selected
from each of the four insertion call sets (P1/RP, P1/SR,
P2/RP, and P2/SR) for polymerase chain reaction (PCR)
validation experiments and from these we experimentally
validated 645 (611 intergenic and 34 exon targeted)
recent polymorphic Alu insertion events, representing
all three strategic approaches, low-coverage, high-coverage, and exon-targeted insertion events (for details see
Stewart et al. 2011). Due to the nature of RP and SR
second-generation sequencing technologies, Alu subfamily classification from this data set was performed
by reconstruction of the supporting fragment reads to
map each candidate insertion against the human reference genome, followed by RepeatMasker (Smit et al.
1996–2010) analysis to identify the Alu subfamily.
The goal of this project was to perform high-resolution
Sanger chain termination DNA sequencing (Sanger et al.
1977) on a subset of at least 50% of these validated polymorphic Alu MEI events to report: 1) Complete Alu sequences
including the variable middle A-rich region and immediate
flanking sequence of the Alu element; 2) precise genomic
insertion coordinates; 3) target site duplications (TSDs), and
Alu subfamily analysis for each locus.

Materials and Methods
Following the original locus-specific PCR validation experiments reported in Stewart et al. (2011), all 34 validated Alu
insertions located in exon-targeted regions were Sanger sequenced. Subsequent detailed analyses (Mills et al. 2011) concluded that the actual locations of these exon-targeted
elements were almost exclusively intronic or untranslated
region (UTR)-overlap with minimal affect to coding exons.
Concurrently in the laboratory, Alu loci from the 611 validated
intergenic insertion events were being randomly selected for
Sanger sequencing. Once a locus was attempted to be sequenced it was considered “selected” and follow-up experiments were conducted until the locus was successfully Sanger
sequenced with confidence. The process continued until we
had roughly 50% of the data set completed. This was an
arbitrary cut off point with the objective being to obtain a
representative subset of ample sample size within a reasonable time frame.
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individuals from Yoruba, Nigeria (YRI), 60 individuals of
European ancestry from Utah (CEU), 30 of Han ancestry
from Beijing, and 30 of Japanese ancestry from Tokyo
(Abecasis et al. 2010; Mills et al. 2011). The “high-coverage
project,” also called “P2” or the “trio project” consisted of
mother–father–offspring trios, one each from CEU and YRI
populations, where each of the six individuals was sequenced
to 42 coverage on average (Abecasis et al. 2010; Mills et al.
2011).
SVs can be balanced (i.e., inversions) or unbalanced (i.e.,
deletions, duplications, insertions). Unbalanced SVs are often
referred to as copy number variants (CNVs) (Mills et al. 2011).
Mobile element insertions (MEIs) are a type of unbalanced
CNV known to be major contributors of structural variation
(Cordaux and Batzer 2009; Xing et al. 2009, 2013; Abecasis
et al. 2010; Beck et al. 2011; Mills et al. 2011; Stewart et al.
2011) with non-LTR (long terminal repeat) retrotransposons,
L1 (long interspersed element 1), SVA, and Alu classes of MEIs
having accumulated in such large copy numbers as to collectively account for one-third or more of the human genome
(Lander et al. 2001; Cordaux and Batzer 2009; de Koning
et al. 2011). Non-LTR retrotransposons have also been implicated in causing a variety of genetic diseases (Deininger and
Batzer 1999; Callinan and Batzer 2006). Although most MEIs
are ancient remnants in the genome, having lost their ability to
replicate, their residual high sequence identity has contributed
to genome instability (Sen et al. 2006; Han et al. 2007; Lee
et al. 2008; Cook et al. 2011) and extensive genome rearrangements. Mobile elements are a source of genome instability
both through insertion and postinsertion mutagenesis
(Cordaux and Batzer 2009; Konkel and Batzer 2010;
Deininger 2011; Ade et al. 2013). Younger non-LTR retrotransposons remain active in the human genome, propagating in
a “copy and paste” mechanism leading to increased genomic
diversity among humans (Xing et al. 2009; Beck et al. 2010;
Hormozdiari et al. 2011; Stewart et al. 2011). Alu elements
are nonautonomous and require the enzymatic machinery of
L1 to mobilize (Dewannieux et al. 2003) yet they are the most
prolific class of MEI in humans in terms of copy number,
having accumulated greater than 1 million copies over the
past 65 Myr (Lander et al. 2001; Batzer and Deininger
2002). The typical full-length human Alu element is about
300 bp long and has a dimeric structure in which the left
monomer contains an RNA polymerase III (pol III) promotor
(A and B boxes), followed by a middle A-rich region, right
monomer and ending in an oligo (dA)-rich tail (Batzer and
Deininger 2002; Deininger 2011; Wagstaff et al. 2012).
Although most Alu copies have ceased to replicate, the current rate of Alu retrotransposition in humans is estimated to
be one new insertion in every 20 live births (Cordaux et al.
2006), resulting in potentially 300 million recent Alu insertions
in human populations globally (Bennett et al. 2008) with a
potential for profound impact on human biology.
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DNA Samples

Oligonucleotide Primer Design
Most oligonucleotide primers used for PCR reactions in this
study were designed for the original validation experiments as
reported previously (Stewart et al. 2011). In cases in which the
original primers were not acceptable for Sanger sequencing,
primers for individual loci were redesigned as needed (supplementary file S3, table S3, Supplementary Material online) using
Primer3 on-line software (Rozen 1998), (http://biotools.
umassmed.edu/bioapps/primer3_www.cgi, last accessed
September 1, 2015). We also designed five primers within
the Alu sequence, three in the forward orientation and two
in the reverse, that were used exclusively for sequencing experiments to obtain a high confidence consensus sequence in
both directions for each Alu in the data set. The internal forward primers sequenced into the A-tail providing a confident
estimation of A-tail length. The internal reverse primers sequenced out the “front” of each Alu confirming the 50 flanking sequence upstream of the Alu element and the precise
preintegration site. Virtual PCR was performed for each locus
using the in silico function of BLAT (Kent 2002) to obtain the

PCR Analysis
PCR amplifications were performed in 25 ml reactions containing 15–50 ng of template DNA; 200 nM of each oligonucleotide primer; 1.5–3.0 mM MgCl2, 10 PCR buffer (1:50 mM
KCl; 10 mM Tris–HCl, pH 8.4); 0.2 mM dNTPs; and 1–2 U Taq
DNA polymerase. PCR reactions were performed under the
following conditions: Initial denaturation at 94  C for 60 s,
followed by 32 cycles of denaturation at 94  C for 30 s, 30 s
at optimum annealing temperature, and extension at 72  C
for 30 s. PCRs were terminated with a final extension at 72  C
for 2 min. 20 ml of each PCR product were fractionated in a
horizontal gel chamber on a 2% agarose gel containing
0.2 mg/ml ethidium bromide for 60–70 min at 175 V. UVfluorescence was used to visualize the DNA fragments and
images were saved using a BioRad ChemiDoc XRS imaging
system (Hercules, CA).

Sanger Sequencing
Four PCR fragments per locus were gel purified using a Wizard
SV gel purification kit (Promega Corporation, Madison, WI,
catalog A9282) according to the manufacturer’s instructions
with the following modification. The 50 ml elution step was
performed twice, resulting in 100 ml, which was then dried in a
SpeedVac (ThermoSavant SPD 111 V). The DNA was reconstituted in 30 ml TVLE (tris very low ethylenediaminetetraacetic
acid [EDTA], 10 mM Tris/0.05 mM EDTA) and 4 ml was used for
chain termination cycle sequencing using BigDye Terminator
v3.1. Cycle sequencing was performed under the following
conditions: After an initial denaturation at 95  C for 2 min, 40
cycles at 95  C for 10 s, 50  C for 5 s, and 60  C for 4 min were
performed followed by a hold at 4  C. Sequencing reactions
were cleaned by standard ethanol precipitation to remove any
unincorporated dye terminators and then stabilized in 15 ml
Hi-Di Formamide (Life Technologies, Inc.). Capillary electrophoresis was performed on an ABI 3130xl Genetic Analyzer
(Applied Biosystems, Inc., Foster City, CA).

Cloning and Sequencing
In rare cases (<1%), sequencing using the PCR primers remained unresolved even after several attempts. When this
occurred, gel-purified PCR products were cloned using a
TOPO TA cloning kit for sequencing (Invitrogen Corporation,
Carlsbad, CA, catalog K4575-40) according to the manufacturer’s instructions. For each candidate locus, at least three
clones were picked from lysogeny broth (LB)/amp plates and
verified for the presence of an insert of the expected size using
colony PCR. Following overnight incubation in LB at 37 C,
plasmid mini-preps were performed using the FastPlasmid
Mini Kit (5 PRIME, Inc., Gaithersburg, MD) according to the
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All DNA samples used for Sanger sequencing were selected
from the PCR validation results showing a “filled site” or Alu
present confirmation in a particular individual. The ID of the
individual used for sequencing as well as the Alu genotype of
that individual (+/+: homozygous present for the insertion; or
+/: heterozygous) is shown in supplementary file S3, tables
S1 and S2, Supplementary Material online, for each locus.
DNA samples for the original PCR validations consisted of a
subset of 25 DNA samples from the 179 Pilot 1 low coverage
samples: Ten European samples (CEPH/Utah USA), NA11881,
NA12043, NA07346, NA07347, NA11894, NA07357,
NA12003, NA11831, NA06986, and NA12828; five African
samples (HAPMAP/YRI) NA18504, NA18870, NA18912,
NA19210, and NA19201; five Chinese samples (HAPMAP/
Han Chinese) NA18572, NA18577, NA18537, NA18563,
and NA18542; and five Japanese samples (HAPMAP/
Japanese, Tokyo) NA18942, NA18943, NA18944,
NA18945, and NA18953. Pilot 2 PCR validation experiments
included six DNA samples, CEU trio: NA12878 (daughter),
NA12891 (father), and NA12892 (mother); and YRI trio:
NA19238 (mother), NA19239 (father), and NA19240
(daughter). These Pilot 1 & 2 DNA samples were purchased
from the Coriell Institute for Medical Research (Camden, NJ).
In addition to the subset of 25 individuals used for the Pilot 1
validations, four more DNA samples from the low coverage
Pilot 1 data set were obtained for subsequent experiments.
DNA samples NA12872, NA12814, NA12815, and NA12044
(CEPH/Utah USA) were purchased from the Coriell Institute for
Medical Research. Then, all 35 samples (25 + 6 + 4) were used
for PCR validations associated with MEI events detected specifically from exon-targeted regions.

estimated PCR product size for the empty (no insertion) and
the filled size (insertion present). Primers were ordered from
Sigma Aldrich (Woodlands, TX).
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manufacturer’s instructions. Generic M13 forward and reverse primers were used for cycle sequencing PCR as described
above.

Sequence Analysis

Results
We report Sanger sequencing results for 343 polymorphic Alu
MEI events from the 1000 Genomes Pilot Project, 309 of the
611 intergenic insertion events representing each of the four
insertion call sets (P1/RP, P1/SR, P2/RP and P2/SR), as well as all
34 validated Alu elements from exon-targeted regions which
resided primarily within intronic and UTR-overlap regions (see
Materials and Methods). These completed Alu consensus sequences (a consensus of multiple Sanger-sequenced amplicons for each locus) along with some genomic flanking

Deletions and Duplicate Calls
One criteria of the original MEI call sets was that all calls were
absent from the human reference genome. Sequencing results identified six loci (of the 309 set; ~2%) which appear to
be lineage-specific deletions from the reference genome
rather than novel Alu insertions. Five were classified as deletions based on sections of flanking sequence on at least one
side of the Alu being deleted from the reference genome and
by alignment with the chimpanzee genome [panTro4]. For the
sixth event, locus #209, the beginning of the Alu sequence is
present in the reference genome followed by a 550-bp deletion (supplementary files S1 and S3, table S1, Supplementary
Material online).
For further analysis we removed the six loci determined to
be deletions (highlighted in red in supplementary file S3, table
S1, Supplementary Material online), and sorted our data set by
insertion coordinates to identify any potential duplicate loci.
As with the original validation sets some redundancy occurred
due to the presence of the same Alu insertion candidate locus
being detected in multiple call sets (Pilot 1 vs. Pilot2 or Illumina
[RP] vs. 454 [SR]) followed by random selection of candidate
loci for validation. Our sequenced loci included four duplicates
from P1 which were called by both Illumina and 454 platforms
(highlighted in blue in supplementary file S3, table S1,
Supplementary Material online). As expected, the nucleotide
sequence including the insertion site of the Alu was identical
between these duplicates. In each case, we elected to remove
the 454 (SR) duplicate. There were also multiple instances in
which the same locus was in both the P1, low-coverage, and
the P2, high-coverage trio data sets. Because P1 and P2 contained different human subjects it was important to record all
the genotype and sequence data, but for the distribution of
Alu subfamilies and subsequent analyses, it was important to
retain only unique novel insertion events. Our sequenced Alu
loci included 11 present in both P1 and P2 data sets
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Following capillary electrophoresis, sequence quality was evaluated using ABI software Sequence Scanner v1.0. Sequence
alignment figures were constructed in BioEdit (Hall 1999) and
a consensus sequence for each locus was determined from
the multiple forward and reverse Sanger sequences obtained
for each locus. Alu elements in the reverse orientation (minus
strand) were reverse complimented to be viewed in BioEdit in
the forward orientation. Once the consensus sequence for
each locus was determined, data were recorded for TSDs,
endonuclease cleavage site, and estimated A-tail length.
Then, a query sequence which included some flanking sequence along with the Alu junction was screened in BLAT
(Kent 2002) to determine the precise insertion coordinates.
The integration site in the reference genome was identified
as the nucleotide junction between the last base matching the
reference genome upstream of the Alu and the adjacent base
(typically the first base following the 30 TSD). Using this convention, the insertion site coordinate was always at the last
base pair of the 50 TSD before the element. This is in contrast
to some coordinates of the 1000 Genomes Pilot release data
set which primarily focused on deletions and therefore the
breakpoint even for MEI events was generally determined as
the first base pair of the 50 TSD, without regard for element
orientation. We initially used human reference genome [hg18]
coordinates for all our analyses to be consistent with the
source data as reported in Stewart et al. (2011), but also
report the [hg19] insertion coordinates for each locus converted using the LiftOver function of the UCSC genome browser (Kent et al. 2002).
The multiple alignment diagram of the new Alu subfamilies
discovered in this study was constructed using the “view
alignment report” option in MegAlign with the ClustalW
algorithm followed by manual formatting of “alignment
report contents” under Options (DNASTAR, Inc. Version 5.0
for Windows). The alignment report output was saved as a
text file, followed by more manual refinement and labeling in
Microsoft Word for Windows.

sequence are available in FASTA format (supplementary file
S1, Supplementary Material online), as GB files in BioEdit (Hall
1999) (supplementary file S2, Supplementary Material online)
and have been deposited in GenBank under accession numbers KT305395–KT305737. A comprehensive summary table
is available as supplementary file S3; tables S1 and S2,
Supplementary Material online. Data for each locus include
the original call set (P1 or P2 and Illumina [RP] or 454 [SR]), the
subject identification number for the individual used for sequencing along with that individual’s population affiliation
and genotype at the respective locus, the genomic insertion
coordinates, the Alu subfamily, the percent divergence from
the subfamily consensus sequence, estimated A-tail length,
and TSDs. Redesigned and supplemental PCR primers used
for Sanger sequencing which differed from the original validation experiments are listed in supplementary file S3, table
S3, Supplementary Material online.
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(highlighted in yellow in supplementary file S3, table S1,
Supplementary Material online). Once again, the nucleotide
sequence including the preintegration site of the Alu insertion
was identical between these duplicates. For consistency, we
removed the P1 duplicate and retained the P2 locus.

Following the removal of the 6 deletion events and 15 duplicate loci, 288 unique intergenic (P1/RP: N = 64, P1/SR:
N = 124, P2/RP: N = 41, and P2/SR: N = 59), and 34 exon-targeted Alu MEI events remained in our data set. These insertions were randomly distributed across the genome based on
the larger full set of MEI events reported previously (Stewart
et al. 2011). Subfamily analysis using RepeatMasker (www.
repeatmaskser.org, last accessed September 1, 2015) (Smit
et al. 1996–2010) detected no appreciable difference in the
Alu subfamily distribution between intergenic and exon-targeted elements and therefore the Alu subfamily distribution
for the combined 322 loci is shown in figure 1. All 322 elements were derived from the AluY lineage with no evidence
of older AluJ or AluS retrotransposition activity. The complete
RepeatMasker output report is available as supplementary file
S4, tables S4 and S5, Supplementary Material online. The
most active human Alu subfamilies are AluYa5 and AluYb8
as reported previously (Carroll et al. 2001; Hormozdiari et al.
2011; Stewart et al. 2011) representing 48% and 24% of our
data set, respectively. The ancestral AluY is considered the
oldest of the “young” Alu subfamilies and the progenitor of
all the subsequent subfamilies of the Y-lineage (Batzer et al.
1996). Yet about 14% of the young Alu elements we
sequenced were identified as AluY, suggesting ongoing retrotransposition of this progenitor subfamily. We also observed
moderate activity of the AluYb9 subfamily as well as lower
levels of recent retrotransposition among ten other Alu subfamilies (fig. 1).

Characterization of Confirmed Novel Alu Insertions
The percent divergence from each subfamily consensus sequence for all 322 novel Alu insertions ranged from 0.0%
to 6.6% with an average of 0.8% and a standard deviation
of 0.7%. The maximum value of 6.6% is for exon-targeted
Alu #51 which is 50 truncated by 98 bp and represents an
extreme outlier in the data set by being more than 8 SD
away from the mean, within the AluYb8 subfamily which
otherwise has a range of 0.0–2.1% divergence. With this
locus removed from the calculation, the maximum value is
4.8% divergence (for a full-length AluY), the average is still
0.8%, and the standard deviation is 0.6%. The distribution of
percent divergence from each subfamily consensus sequence
is shown in figure 2. A total of 30 elements (N = 26 Ya5, N = 3
Yb9, and N = 1 Yb8) were scored by RepeatMasker (Smit et al.
1996–2010) as having 0.0% divergence from their respective
consensus sequences (about 9.3% of the data set). All 156

FIG. 1.—Distribution of active Alu subfamilies. The percent membership to each Alu subfamily based on 322 unique Alu elements in the
RepeatMasker subfamily analysis. The category “Other” is comprised
one Alu element each from subfamilies Ya8, Yc1, Yh7, and Yj4.

AluYa5 elements (yellow) and 75 of 76 AluYb8 elements
(green) were 2% diverged from their respective consensus
sequence, providing strong support for their recent genomic
integration. As expected the ancestral AluY subfamily (orange)
showed the broadest distribution of percent divergence from
the AluY consensus sequence. Typically, as percent divergence
increases the estimated age of the insertion event also increases, as older elements have more time to accumulate
random mutations. However, because this data set is comprised exclusively of proven young polymorphic Alu elements,
the broad range in divergence is suggestive of the amplification of secondary source elements, or multiple members
within the AluY subfamily capable of making new copies,
thus increasing diversity.
The distribution of endonuclease cleavage sites for the 322
Sanger-sequenced Alu insertions is graphically displayed in
WebLogo format (Schneider and Stephens 1990; Crooks
et al. 2004) (fig. 3) and listed individually for each locus in
supplementary file S3, tables S1 and S2, Supplementary
Material online. Although the most common nucleotide at
each position, as depicted by letter size in figure 3, corresponds to the typical 50 -TTTT/AA-30 recognition sequence for
L1 endonuclease (Feng et al. 1996; Jurka 1997; Konkel et al.
2010), only 72 elements (22.5%) contained an exact match to
that sequence, whereas the majority did not, further underlining that the human/primate-specific L1 endonuclease is not
entirely restricted to the canonical 50 -TTTT/AA-30 endonuclease cleavage site. In particular, the second nucleotide of the
endonuclease cleavage site frequently (21.3% of elements)
contained a cytosine instead of a tyrosine. In fact, 50 -TCTT/
AA-30 has been reported previously as the second most
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FIG. 3.—Distribution of endonuclease cleavage sites for 322 unique Alu elements as a WebLogo diagram. The nucleotide frequency at each of the six
positions is graphically proportional to the height of each letter.

frequently observed hexa-nucleotide pattern adjacent to the
primary nick site associated with retrotransposon insertions in
the genome (Jurka 1997) and in vitro (Morrish et al. 2002),
consistent with our data set.
All 322 analyzed Alu elements were 30 intact displaying
A-rich tails of varying lengths, and nearly all (320) were
surrounded by TSDs consistent with the target-primed reverse
transcription (TPRT) integration mechanism using L1 endonuclease and reverse transcriptase (Luan et al. 1993). We found
no evidence that any of these Alu insertions integrated
through a recombination event, indicating that the original
calling algorithm selected for TPRT events. Two exon-targeted
Alu insertions, #30 and #40 (see supplementary file S1,
Supplementary Material online), lacked clearly defined TSDs,
but were also severely 50 truncated, 67 and 160 bp,

respectively. The most likely endonuclease cleavage site was
determined to be 50 -TTTT/AA-30 in both cases. Thus, all Alu
insertions, including the truncated ones, in the data set are
consistent with proper insertion events generated through the
enzymatic machinery of L1. Compared with the chimpanzee
genome [panTro4], the integration of exon-targeted Alu elements #30 and #40 appears to be combined with short deletions of A-T rich stretches of approximately 19 and 10 bp,
respectively, obscuring the TSDs during these 50 truncated insertion events. In total, 14% (45 of 322) of the sequenced Alu
insertions were 50 truncated as defined here as having a start
position after the third base pair of the Alu sequence. The
severity of 50 truncation ranged from a start position of 4 bp
to a start position of 193 bp within the Alu sequence, N = 14
elements 4–25 bp; N = 20 elements 26–50 bp; N = 5 elements
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FIG. 2.—Distribution of the percent divergence from the subfamily consensus sequence for each Alu element based on RepeatMasker. All Ya5 elements
(yellow) and over 96% of all the Alu elements have 2% divergence from the respective consensus sequences. Alu elements with greater than 2%
divergence are primarily AluY elements in addition to one each Yb8 and Ye5 elements.
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these 28 represent our most likely source candidates from this
data set.

Evolution of Alu Subfamilies
Our data set contained two Alu elements initially identified as
belonging to subfamily AluYa8, but upon alignment with the
consensus sequences for AluY, Ya5 and Ya8 were found to be
50 truncated to the extent that the three diagnostic substitutions defining an Ya8 as different from an Ya5 were not available. As such, these two loci could not be authenticated as
belonging to the AluYa8 subfamily. Locus 345 was the only
full-length AluYa8 element in our sequenced data set and it
also possesses all the known hallmarks of being retrotransposition competent, as described above. This is just one example
of the benefit of careful sequence analysis using known subfamily consensus sequences. Recognizing the potential for
such confounding factors, we constructed Alu sequence alignments for the three primary subfamilies identified in our data
set, AluY, AluYb8 and AluYa5, comparing our Sanger-generated sequences to each subfamily consensus sequence (Jurka
2000; Jurka et al. 2005). These alignments unveiled an abundance of variation within each subfamily providing evidence
for a dynamic and continuous evolution of human Alu subfamilies (fig. 4A–C).
Of the 45 AluY elements sequenced, 42 were considered
full length for the purpose of subfamily determination (at least
275 bp). Of these 42, nearly 80% (N = 33) were 2% diverged from the ancestral AluY consensus sequence, consistent with being relatively young. Although none was exact
match to the AluY consensus sequence in this data set, several
(N = 6) only had one substitution when the variable middle
A-rich region was excluded, a G to A transition at either position 145 or 148. The four AluY loci with the G to A substitution at position 145 were loci 63, 204, 280, and 445. Based
on the reported evolution of Ya-lineage diagnostic nucleotides, these four elements can be considered members of
the Ya1 subfamily (Shen et al. 1991; Roy et al. 2000). The
two AluY loci with a single G to A substitution at position 148
were loci 234 and 616. This single change from the AluY
consensus sequence corresponds with an AluYc1 as defined
previously by Roy-Engel et al. (2001) and others (Garber et al.
2005). In total, our AluY data set contained 17 full-length
elements that shared this substitution, the two previously
mentioned, eight with one additional substitution, including
loci 156 and 357 matching the AluYc2 consensus sequence
(Jurka et al. 2002) and seven with two or more additional
mutations. Locus 357 also possesses all the known hallmarks
of being a potential source element as described above.
We also identified four other AluY loci in our data set with
evidence of subfamily evolution along the Ya-lineage. Locus
674 and exon-targeted locus 34 both have two of the five
AluYa5 diagnostic substitutions, the T to C transition at position 89 (1st of 5) and the C to T GpG mutation at position 174
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21–100 bp; and N = 6 elements 101–193 bp (see supplementary files S1 and S3, Supplementary Material online).
Of the 320 sequenced Alu elements with intact TSDs, 93%
(297) contained perfect TSDs, matching exactly on both the
50 - and 30 -ends of the element. Only 7% of the analyzed
Alu elements displayed TSDs with mismatches between the
50 - and 30 -ends and almost all of these were single nucleotide
potential mismatches based on the sequencing results. This is
consistent with very recent Alu insertion events with insufficient time for decay. The TSD lengths of the analyzed elements were generally within the expected range of 6–21 bp
(Moran et al. 1996; Konkel et al. 2010), with the range across
our loci being 7–22 bp with the average and median both
being 14 bp.
The vast majority of A-rich tails were characterized as perfect homopolymeric stretches without interruptions. Only 7%
of the insertions contained A-tails with one or more nucleotide
substitutions. Because nearly all Alu insertions were sequenced from PCR products, the exact size of each A-tail
was impossible to determine as forward and reverse sequences typically terminated within the homopolymeric
stretch of adenosines. However, we estimated the approximate size of each A-tail on the basis of the Sanger sequencing
(see Materials and Methods). Sequence alignments estimated
that the smallest A-tail was 13 bp and the largest was 62 bp,
with an average length of approximately 29 bp. The intactness
of the A-tails in addition to the relatively long size of the A-tails
further supports the relatively young age of these insertions
(Roy-Engel et al. 2002). Longer A-tails free of nucleotide substitutions are among the known characteristics of active
source elements (Roy-Engel et al. 2002; Dewannieux and
Heidmann 2005).
Another factor critical for Alu replication is the structural
integrity of internal RNA Pol III promotor A and B boxes located
in the left monomer (Mills et al. 2007; Bennett et al. 2008;
Comeaux et al. 2009). Also important is the distance between
the 30 A-tail of the element and the first downstream Pol III
TTTT termination signal, where a distance of about 15 bp or
greater results in a strong decrease in retrotransposition ability
(Comeaux et al. 2009). Our data set contained 23 Alu insertions (7%) in which the TTTT termination was within the 30
TSD or immediately after, and an additional 20 loci where the
first downstream termination signal was within 15 bp.
Filtering these 43 loci for only full-length elements with
intact left monomers (no 50 truncation) that also have an
intact A-tail greater than 20 bp in length, resulted in 28 Alu
elements (about 8.7% of the data set) from seven different
subfamilies having all the traditional hallmarks of source elements with the potential ability to generate new insertions.
These are highlighted in green in supplementary file S3, tables
S1 and S2, Supplementary Material online. We certainly do
not mean to imply that other elements in the data set are
necessarily unable to replicate, only that the identification of
true Alu source elements is complicated and imprecise and
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(4th of 5). Locus 429 also has two of the five AluYa5 diagnostic nucleotides, the 1st of 5 as described above, and the C
to A transversion at position 96 (2nd of 5). Therefore, these
are variants of the Ya2 lineage. In addition, Alu locus 92 is a
member of the Ya3 lineage and contains three of the five Ya5
diagnostic changes, the T to C transition at position 89, the G
to A at position 145, and the C to T GpG mutation at position
174. The forth, Alu locus 143 contains all five of the AluYa5
diagnostic nucleotide substitutions (supplementary file S5,
Supplementary Material online, alignment file). Alu locus
143 was initially classified as a member of the AluYk3 subfamily, but we were unable to identify a known consensus
sequence available for this subfamily for comparison. Also
noting that this sequence did not appear to be intermittent
between an AluY and an Yk4 (for which there is a consensus
sequence available), we determined it was prudent to classify

this locus as an AluY until further analysis, even though it was
2.9% diverged from the AluY consensus sequence. Upon
alignment, Alu locus 143 contains all five of the AluYa5 diagnostic nucleotide substitutions. This has been noted in supplementary file S3, table S1, Supplementary Material online.
AluY sequence alignments also provided evidence for evolution along the Yb-lineage. Alu locus 269 has the first and
third diagnostic substitutions of the Yb8 lineage, consistent
with the Yb2.6 subfamily (Carroll et al. 2001). Also, locus 733,
at 3% diverged from the AluY consensus sequence, contains
the first six of the eight Yb8 diagnostic changes, lacking only
the C to G transversion for the seventh substitution and the
duplication as the eighth change near the 30 -end of the element. This is consistent with the Yb6.2 subfamily (Carroll et al.
2001). A sequence alignment of our AluY loci is available in
BioEdit (Hall 1999) as supplementary file S5, Supplementary
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FIG. 4.—High-resolution distribution of Alu subfamilies following sequence alignment analysis for the three primary subfamilies identified in our data set.
(A) 42 AluY elements, (B) 67 AluYb8 and 11 Yb9 elements and (C) 149 AluYa5 elements. Red font indicates subfamilies discovered in this study.
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also reported in the supplementary data of Ahmed et al.
(2013), Additional file 3, table S2, Supplementary Material
online, as ID P1_MEI_27 and ID P1_MEI_275, respectively.
However, our identification of locus 58 as belonging to the
newly defined Yb8a1 subfamily does not appear to have been
reported previously.
Our Yb8 sequence alignments also revealed ten other Alu
insertion events, containing all eight diagnostic changes, plus
a shared G to A transition at position 260 (loci 100, 264, 275,
298, 323, 348, 352, 384, 413, and exon-targeted locus 44).
For loci 100, 323, 352, 384 and exon-targeted locus 44, this is
the only additional substitution (supplementary file S6,
Supplementary Material online). We have named these
Yb8b1 (fig. 5) following the standardized nomenclature
(Batzer et al. 1996) because Yb8a1 was recently used by
Ahmed et al. (2013) and this represents a different single
variant of Yb8. A BLAT (Kent 2002) search using locus 384
finds 25 exact matches in [hg19] (table 2) and zero exact
matches in chimpanzee [panTro4], further evidence that this
is a separate human-specific subfamily. As with Yb7a3, these
exact matches from the reference genome are generally located in high repeat regions with 7 of the 25 insertions occurring directly into another repeat, they are relatively young
in appearance (0.7% average divergence from Yb8), and all
were confirmed by sequence alignments to be exact matches
to locus 327 (exceptions: chr8:113225903 has an extra adenosine in the middle A-rich region; chr3:155410974 is missing
the first G of the Alu element at position 1) (data not shown).
A more refined breakdown of the AluYb8/9 subfamily evolution in our data set is shown in figure 4B.
The most abundant subfamily in our data set was AluYa5
(N = 156) (Batzer et al. 1990, 1996) comprising about 48% of
the elements we Sanger sequenced. Of the 156 Ya5 loci, 149
were considered full length for the purpose of subfamily determination (at least 275 bp). Sequence alignments (supplementary file S7, Supplementary Material online) identified
considerable substructure within the Ya5 data set suggestive
of continuous ongoing evolution of Alu subfamilies. Not unexpectedly, six loci were identified as Ya5a2 elements, 251,
291, 339, 373, 583, and 729. Of these six, loci 251, 291, and
583 were exact matches to the consensus sequence for
theYa5a2 subfamily as characterized by Roy et al. (2000) (supplementary file S7, Supplementary Material online). Most notably our Ya5 data set contained a total of 11 elements
missing the fifth diagnostic Ya5 substitution (G to C at position
237) and instead shared a C to T CpG mutation at adjacent
position 236. Six of these, loci 168, 394, 283, 350, 671, and
742 had no other random mutations, whereas the other five,
loci 214, 270, 353, 368 and exon-targeted locus 52 contained
additional substitutions. This does not match the consensus
sequence of any previously characterized Alu subfamily. We
have named these AluYa4a1 for the four diagnostic changes
of an Ya5 plus one additional substitution (fig. 5). A BLAT
search using locus 168 provides 13 exact matches for this
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Material online. Therefore, at higher resolution the 42 fulllength AluY elements obtained from Sanger sequence alignments show gradients of subfamily substructure among
young AluY insertions (fig. 4A).
We also performed sequence alignments of all the AluYb8
(N = 77) and AluYb9 (N = 13) elements from our data set (supplementary file S6, Supplementary Material online). Of the 77
Yb8 elements, 67 were full length, and of the 13 Yb9 elements, 11 were considered full length (at least 275 bp) for
subfamily determination. Loci 36 and 598 lack the Yb8 diagnostic T to C substitution at position 144, consistent with the
previously described Yb7.2 subfamily (Carroll et al. 2001). We
recovered seven Yb8 elements lacking the diagnostic CpG
mutation at position 64 (loci 8, 116, 216, 262, 327, 371,
and 381), consistent with the Yb7.3 subfamily (Carroll et al.
2001). Of these, locus 216 was also lacking two additional
diagnostic nucleotides of the Yb8 subfamily, giving the appearance of an intermediate Yb5 element along the lineage.
Locus 216 is also one of our 28 potential source elements in
the data set. In addition to lacking the CpG mutation at position 64, loci 8, 116, and 327 of the Yb7 elements also shared
three additional unique modifications (G to A at position 207,
C to T at position 243, and G to A at position 268) which do
not appear to match the consensus sequence of any previously characterized Alu subfamily. For loci 8 and 327, these
are the only other substitutions. We have named these Yb7a3
following the standardized nomenclature for Alu repeats
(Batzer et al. 1996) (fig. 5). A BLAT (Kent 2002) search
using the locus 327 consensus sequence reveals eight exact
matches in [hg19] (table 1) and zero exact matches in chimpanzee [panTro4] indicating this is a human-specific independent subfamily. These eight loci from the reference genome
are generally located in high repeat regions with four of the
eight insertions occurring directly into another repeat, such as
an MIR, (mammalian interspersed repeat) or L1MC (an ancient
L1 subfamily), they are relatively young in appearance (1.6%
average divergence from theYb8 consensus sequence) and all
were confirmed by sequence alignments to be exact matches
to locus 327 (data not shown).
Ahmed et al. (2013) recently reported the identification of
three new AluYb subfamilies they termed, Yb8a1, Yb10 and
Yb11. Using the consensus sequences provided in that report,
we screened our data set and identified one locus corresponding to each of these three new subfamilies (see supplementary
file S6, Supplementary Material online, sequence alignment).
Our locus 58 (Yb8) contains the G to A substitution at position
259, consistent with Yb8a1 as defined by Ahmed et al.
(2013). Our locus 325 shares this same change as well as
having the G at position 174, the diagnostic ninth mutation
defining Yb9 from Yb8, together now termed AluYb10
(Ahmed et al. 2013). Our locus 613 has both these mutations
and in addition has the T insertion at position 200-1, diagnostic changes of the recently reported Yb11 subfamily (Wang
et al. 2006; Ahmed et al. 2013). Our Yb10 and Yb11 loci are
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Table 1
[hg19] Coordinates of Yb7a3 Exact Matches
CHR
6
4
17
X
7
2
14
1

STR

Start

End

Span

Identity (%)




+
+
+
+
+

158876118
64442586
75236003
81065458
31070590
87339719
33520199
66079155

158876405
64442873
75236290
81065745
31070877
87340006
33520486
66079442

288
288
288
288
288
288
288
288

100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00

consensus sequence in [hg19] (table 3) and zero exact
matches in chimpanzee [panTro4] indicating this is a
human-specific subfamily. In addition, loci 350 and 671,
exact matches to this consensus sequence, also have the

TTTT pol III termination signal within 15 bp of the A-tail, and
are among our 28 candidate source elements with the potential to generate new copies. Furthermore, [hg19] locus
chr10:64784930 displays a perfect A-tail 38 bp long and the
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FIG. 5.—An alignment diagram showing the consensus sequence of the three new subfamilies discovered in this study, AluYb7a3, Yb8b1, and Ya4a1.
The consensus sequence for AluY is shown on the top row along with a base pair ruler. The dots represent the same nucleotide as the consensus AluY.
Diagnostic mutations of AluYb8 are highlighted in yellow and the five diagnostic mutations of AluYa5 are highlighted in green. Diagnostic nucleotide
changes of the new subfamilies, Yb7a3, Yb8b1 and Ya4a1 are highlighted in pink, blue and gray, respectively.
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Table 2
[hg19] Coordinates of AluYb8b1 Exact Matches
CHR

STR

Start

End

Span

Identity (%)















+
+
+
+
+
+
+
+
+

+

190253873
167108142
81302578
54843357
35051698
155891208
57111577
14823017
74601478
114215012
84484513
113940842
220285488
8493632
73190208
38513023
24452853
3873218
16257078
33621667
37061647
58809303
81687798
113225903
155410974

190254160
167108429
81302865
54843644
35051985
155891495
57111864
14823304
74601765
114215299
84484800
113941129
220285775
8493919
73190495
38513310
24453140
3873505
16257365
33621954
37061934
58809590
81688085
113226191
155411260

288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
288
289
287

100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00

TTTT termination signal within the 30 TSD (data not shown).
We also identified numerous other matches to previously
identified subfamilies of the Ya-lineage (Shen et al. 1991;
Roy et al. 2000; Jurka et al. 2002) summarized in table 4. A
more refined illustration of the subfamily evolution within our
Ya5 elements is shown as figure 4C. When we redraw the
distribution of active human Alu subfamilies in our data set to
incorporate the combined findings of this study, a more complex network emerges (fig. 6) providing a more realistic illustration of the dynamic evolution of Alu subfamilies.

Discussion
The purpose of this study was not necessarily to identify new
Alu subfamilies or to potentially introduce more confusion
with regard to Alu nomenclature. Presently, there are
instances in the literature where more than one consensus
sequence has been reported for a given subfamily name,
such as AluYa1 (Roy et al. 2000; Jurka et al. 2002) and
Yb10 (Ahmed et al. 2013; Teixeira-Silva et al. 2013), or
conversely for which a single consensus sequence has been
given different names, such as Yc (Smit et al. 1996–2010)
and Yd (Jurka 2000; Xing et al. 2003) as subfamilies are
discovered by multiple investigators at nearly the same
time. However, a systematic evaluation of our Sanger-

sequenced Alu elements revealed a dynamic and continuous
process of Alu subfamily evolution worthy of report and
discussion. It has long been recognized that the evolution
of Alu subfamilies is a complex proliferation in which the
“tree” of subfamilies is more “bush-like” in appearance
with many active secondary source elements sprouting
new lineages (Cordaux et al. 2004; Price et al. 2004).
The findings of this study support a “bush-like” evolutionary model and are consistent with the modified “master
gene” model of Alu amplification, or “stealth model” of
Alu amplification where a few members remain active over
time to preserve the lineage (Deininger et al. 1992; Han et al.
2005). Sequence alignment analyses of the three most prolific
subfamilies in our data set, AluY, Yb8/9 and Ya5, revealed the
existence of at least three new human-specific Alu subfamilies
actively propagating new copies in human populations.
Traditionally, a single CpG mutation, such as the diagnostic
variant defining AluYa4a1, would not warrant naming a new
Alu subfamily simply because CpG sites have six to ten times
faster mutation rates than non-CpG sites (Labuda and Striker
1989; Batzer et al. 1990; Xing et al. 2004), increasing the
potential for independently occurring random mutation
events rather than authentic diagnostic variants. However,
given that we identified 24 independent insertion events
matching this variation of the AluYa5 lineage and at least
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4
4
4
3
3
2
19
18
16
12
12
11
1
1
7
7
5
3
21
20
18
11
1
8
3
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Table 3
[hg19] Coordinates of Ya4a1 Exact Matches
CHR

STR

Start

End

Span

Identity (%)







+
+
+
+
+
+


108225804
102476075
33200890
17522260
5933644
64784930
56353698
25044613
24091623
174705078
148844387
32661973
7773890

108226084
102476355
33201170
17522540
5933924
64785210
56353978
25044893
24091903
174705358
148844667
32662253
7774171

281
281
281
281
281
281
281
281
281
281
281
281
282

100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00
100.00

Table 4
Distribution of AluYa5 Elements Based on Sequence Alignments

% Divergence from Ya5 consensus
Ya5
Ya5a1
Ya5a2
Ya5b1
Ya5c1
Ya3.1
Ya3.3
Ya3.4
Ya4.2
Ya4.3
Ya4.4
Ya4.5 (Ya4)
Ya4a1
Total

Set 1

Set 2

Set 3

Set 4

Total

0.0
24
0
0
0
0
0
0
0
0
0
0
0
0
24

0.3
31
0
5
2
4
0
0
0
3
2
0
4
0
51

0.4 to 0.9
17
2
1
0
0
0
0
0
0
2
3
0
5
30

1.0 to 1.9
31
1
0
0
0
2
2
2
0
0
0
0
6
44

103
3
6
2
4
2
2
2
3
4
3
4
11
149

the 11 from our data set are confirmed to be young polymorphic events, we are confident in reporting this as a new actively propagating human-specific Alu subfamily.
All the Alu insertion events identified in this study were
derived from the AluY lineage. We did not find any evidence
of older AluJ or AluS subfamily amplification in these human
populations. This is in contrast to some previous reports (Mills
et al. 2006; Hormozdiari et al. 2011). However, in these previous studies the loci were computationally ascertained using
nonoverlapping data sets. Although it has been well established that Alu subfamilies greater than 20 Myr old can still
have active members (Johanning et al. 2003; Salem et al.
2005), our findings suggest that in vivo retrotransposition of
AluS is minimal in humans. Bennett et al. (2008) demonstrated AluS activity using a plasmid-based mobilization
assay but concluded that sequence decay of older AluS elements in vivo occurred more rapidly than the propagation of
new copies, supporting a model for their extinction. In

Reference
RepeatMasker, Smit et al. (1996–2010)
Batzer et al. (1990); Batzer et al. (1996)
Roy et al. (2000)
Roy et al. (2000)
Roy et al. (2000)
Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000)
Shen et al. (1991); Roy et al. (2000); Jurka et al. (2002)
This study

general, these findings are consistent with cell culture Alu
mobilization assays. In a recent study, Alu elements that
were pol III-bound lacked the sequence characteristics important for retrotransposition and the majority of these pol IIIbound Alu loci belonged to the older AluS and AluJ subfamilies (Oler et al. 2012). Whereas, the plasmid-based mobilization assay reported that AluY and all of the younger AluY
subfamilies demonstrated activity (Bennett et al. 2008). The
sequence features of the Alu insertion events identified in this
study are also comparable to those recovered from tissue culture assays (Wagstaff et al. 2012).
Can the results of this study help us to estimate the number
of source Alu driver elements in the human genome? We
identified 28 potential source elements from our data set
alone based on the traditional hallmarks associated with retrotransposition activity, two of which belong to the new
AluYa4a1 subfamily. We also report the bush-like proliferation
of at least 42 active Alu subfamilies from our data set (as
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X
7
5
21
17
10
7
7
5
3
3
18
8
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shown in fig. 6). Given that each active Alu subfamily must
have at least one source element by definition, then the
human genome must contain a minimum of 42 active driver
Alu elements. Further, it is estimated that about 15% of Alu
subfamily members can remain active as secondary source
elements continuing to generate new subfamily members
(Cordaux et al. 2004). Extrapolating these numbers means
that an individual human genome could realistically harbor
several hundred source driver elements and potentially many
more.
The purpose of this study was to report the complete sequences for a broad subset of validated Alu insertions from
the Pilot 1000 Genomes Project. A comprehensive analysis of
the sequence structure for 322 unique polymorphic Alu MEI
events illustrates that their impact on human genome structural variation is dynamic and ongoing. Separating AluY elements into smaller and more refined subfamilies with evidence
of active proliferation is undoubtedly far from complete. We
can expect this to continue into the foreseeable future as detection algorithms continue to improve. Enhanced sensitivity

and accuracy of MEI detection methods will undoubtedly
reveal a greater number of rare population-specific and
novel Alu insertions from the ongoing 1000 Genomes
Project as well as from other strategies which take advantage
of emerging technology in high-throughput-targeted sequencing. By understanding more about the complex patterns
of Alu proliferation we can gain further insight into their
impact on structural variation in human populations.

Supplementary Material
Supplementary files S1–S8 including tables S1–S5 are available
at Genome Biology and Evolution online (http://www.gbe.
oxfordjournals.org/).
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FIG. 6.—A schematic drawing of a network diagram for the high-resolution distribution of Alu subfamilies analyzed in this study to illustrate the “bushlike” evolutionary tree. The diameter of each primary node is roughly proportional to the number of elements within the subfamily (AluY: N = 27; Yb8: N = 47
and Ya5: N = 103), whereas the smallest node equals a single element (i.e., Ya8, Yb10, Yj4, etc.). The distance between nodes represents the number of
nucleotide substitutions from the most recent ancestral node (solid lines). For example, Yb7a3 is three substitution lengths from the Yb7 node. Dashed lines
indicate nodes with different combinations of the same number of diagnostic variants, without an additional substitution. For example, the dashed lines
branching from theYa3 and Ya4 nodes depict the Ya3.1, Ya3.3, Ya3.4 or Ya4.2, Ya4.3 and Ya4.4 elements in our data set, as defined by Shen et al. (1991)
and Roy et al. (2000). The dashed lines branching from the Yb7 node depict Yb7.2 and Yb7.3 elements in our data set, as defined by Carroll et al. (2001). The
AluY lineage is shown in orange, Yb8 in green, and Ya5 in yellow. The RM subscript at the base of the AluYc1 node shown in black denotes this as a
RepeatMasker-defined consensus sequence, as opposed to Yc1 as defined by Roy-Engel et al. (2001) and others. A red star within the node represents the
three new subfamilies discovered in this study.
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